Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Cosmos Health inaugurated a state-of-the-art capsule production line at Cana Laboratories and secured a five-year contract with Provident Pharmaceuticals to manufacture 385,000 CERTORUN units, equal to 77,000 per year. CERTORUN, sertraline hydrochloride, is an SSRI used for depression and anxiety, produced in 50 mg and 100 mg capsule strengths on Cana's new ACG fill line as part of ongoing manufacturing upgrades. The arrangement builds on Cana’s track record of contract manufacturing for products such as DE3-SOLE, MIOREL, CALCIFOLIN, and DEXA-DOSE. Cosmos Health CEO Greg Siokas said Cana’s division provides high-margin, recurring revenue with multi-year visibility, diversifying the order book across CNS, musculoskeletal, vitamin, and anti-inflammatory categories while expanding European GMP-certified capacity to secure additional contracts and accelerate growth.